Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 16.65
-0.40 (-2.35%)
Jun 4, 2026, 10:53 AM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 408.88 million as of June 4, 2026. Its market cap has increased by 9.20% in one year.
Market Cap
408.88M
Enterprise Value
546.52M
Revenue
571.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.65
Market Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 408.88M, an increase of 266.07%. That is a compound annual growth rate of 6.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 408.88M | -28.36% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.12B |
| Nordhealth AS | 2.06B |
| Circio Holding ASA | 2.03B |
| Photocure ASA | 1.59B |
| Lytix Biopharma ASA | 769.00M |
| Omda AS | 738.28M |
| Gentian Diagnostics ASA | 582.79M |
| Zelluna ASA | 554.29M |